Terazosin effect on the treatment of urinary tract obstruction symptoms in wome
Phase 2
Recruiting
- Conditions
- rinary obstruction symptoms in women.
- Registration Number
- IRCT20221223056903N1
- Lead Sponsor
- Sabzevar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 110
Inclusion Criteria
All women over the age of 18 years who complain of obstructive symptoms and go to the urology treatment of Vaesi Hospital or a private urology office are included in the study.
Exclusion Criteria
causing drug side effects such as dizziness or orthostatic hypotension
???Lack of informed consent to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rinary obstruction symptoms in women. Timepoint: Measuring the average urine volume with uroflowmetry and completing the International Prostate Symptom Scoring Questionnaire (IPSS) at the beginning of the study and one month after taking the drug. Method of measurement: Uroflowmetry and International Prostate Symptom Scoring Questionnaire (IPSS) questionnaire.
- Secondary Outcome Measures
Name Time Method